IVU Traffic Technologies AG

  • WKN: 744850
  • ISIN: DE0007448508
  • Land: Deutschland

Nachricht vom 27.09.2021 | 11:10

IVU Traffic Technologies AG ends share buyback

IVU Traffic Technologies AG / Key word(s): Share Buyback
IVU Traffic Technologies AG ends share buyback

27-Sep-2021 / 11:10 CET/CEST
Disclosure of an inside information acc. to Article 17 MAR of the Regulation (EU) No 596/2014, transmitted by DGAP - a service of EQS Group AG.
The issuer is solely responsible for the content of this announcement.


Ad-hoc release pursuant to Article 17 MAR
IVU Traffic Technologies AG

ISIN DE0007448508
Listing: Frankfurt Stock Exchange in the sub-segment of the regulated market with additional post-admission obligations (Prime Standard)

Berlin, 27 September 2021

IVU Traffic Technologies AG ends share buyback

On 14 September 2021, IVU Traffic Technologies AG has announced a share buy-back programme in accordance with Article 5 Paragraph 1 letter a) of Regulation (EU) No. 596/2014 and Article 2 Paragraph 1 of Delegate Regulation (EU) No. 2016/1052. In the period from 14 September 2021 up to and including 31 October 2021, up to 30,000 shares (ISIN DE0007448508) with a maximum value of €600,000 (excluding incidental acquisition costs) were to be acquired via the stock exchange.

The total number of shares bought back by IVU Traffic Technologies AG since 14 September 2021 within the share buyback programme amounts to 30,000 shares. This corresponds to 0.17% of the share capital of IVU Traffic Technologies AG. The Executive Board has thus terminated the buyback programme.

The acquisition of the shares was carried out on the basis of the ad-hoc announcement of 14 September 2021 by a bank commissioned by the company exclusively via the stock exchange (XETRA trading).

Detailed information is available on the Company's website www.ivu.com under Investors/IVU Share.

Contact:
Leon Joneleit
Investor Relations
IVU Traffic Technologies AG
Bundesallee 88, 12161 Berlin, Germany
T +49.30.85906-0
ir@ivu.de
www.ivu.com


27-Sep-2021 CET/CEST The DGAP Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases.
Archive at www.dgap.de



show this

GBC im Fokus

IGEA Pharma N.V. Realignment to CBD extraction

The goal is to become the quality and cost leader in the field of CBD in Europe. To this end, a GMP pharma compliant plant is being built in Switzerland. The supercritical CO2 extraction process is to be used to achieve the highest standard of quality. The CBD market is growing strongly and with the focus on quality leadership and pure extraction, IGEA Pharma's new business model should be able to occupy an attractive niche market. With the proprietary supercritical CO2-extraction technology, other markets such as vanilla, rose or rosemary can be developed in the medium term. Based on our DCF model, we have determined a fair value of € 1.05 (CHF 1.13) per share and assign a BUY rating.

News im Fokus

Allianz SE: Allianz kündigt Abschluss eines Rückversicherungsvertrages in den USA an

03. Dezember 2021, 07:03

Aktueller Webcast

Deutsche Konsum REIT-AG

FY 2020/2021 Financial Results

16. Dezember 2021

Aktuelle Research-Studie

CEWE Stiftung & Co. KGaA

Original-Research: CEWE Stiftung & Co. KGaA (von GSC Research GmbH): Kaufen

02. Dezember 2021